Breaking Through Research Bottlenecks: Starter Domestic Antibodies as Your Reliable Scientific Partner Amid Escalating Tariffs
On April 2nd, U.S. President Trump signed two executive orders establishing a 10% "baseline tariff" on all trading partners, with additional tariffs up to 34% imposed on China and several other countries. By April 8th, the tariff rate on Chinese imports to the U.S. was further increased to 84%. Amid these escalating trade tensions, researchers worldwide are facing significant challenges from rising costs of reagents and consumables. Starter, a leading domestic antibody manufacturer, stands ready to be your steadfast research partner, offering tariff-free solutions with our premium-quality antibodies.
A New Benchmark in Domestic Alternatives: Internationally Certified Quality Overcoming Import Antibody Challenges
As international trade conflicts intensify, imported antibodies face three major challenges: high costs, elevated transportation risks, and prolonged delivery times. Starter's R&D team, with fifteen years of expertise in antibody development, has established comprehensive technological capabilities spanning from antibody cloning to industrial-scale production. Leveraging our proprietary rabbit single B-cell antibody platform, recombinant protein expression system, pathology-grade IHC development platform, and eight validation systems (including flow cytometry, ELISA, and immunohistochemistry), we have successfully developed over 5,000 antibody products. Our manufacturing facilities are certified under EU Directive 98/79/EC, ISO9001, and ISO13485 standards, with product performance validated by global clients as meeting international premium standards. Compared to imported antibodies, Starter products deliver equivalent sensitivity and specificity while reducing costs by 30-50% and shortening delivery times to 2-4 weeks, ensuring your research progresses unimpeded by tariff fluctuations or logistics delays.
Recombinant Rabbit Monoclonal Antibody Platform: Revolutionizing Antibody Development
End-to-End Solutions: From Basic Research to IVD Raw Materials
To address potential supply chain disruptions from U.S. technology restrictions, Starter has built a comprehensive antibody ecosystem covering the entire R&D continuum:
Research Tools: 2,000+ high-quality primary antibodies for diverse applications, one-step ELISA kits enabling "sample-to-result" detection within one hour, and universal secondary antibody kits compatible with 95% of IHC applications.
IVD Core Components: CDx/IVD-grade antigens and antibodies that have enabled diagnostic manufacturers to replace imported materials.
Custom Development: Our single B-cell platform facilitates high-quality development of challenging antibodies, breaking the technological monopoly.
Cutting-Edge Technology with a Commitment to Scientific Advancement
"Ensuring no research is hindered by antibody availability" is not just our response to current trade tensions, but a fundamental principle embedded in our corporate DNA. Backed by extensive resources, we have established a nationwide warehousing and logistics network with five automated order systems to guarantee reliable delivery. Our responsive technical support team provides end-to-end experimental assistance.
"Trade barriers may rise and fall, but scientific exploration knows no borders." Hangzhou Starter stands ready with robust scientific capabilities as our shield, our mission from antibody to discovery as our armor, and our commitment to integrity and progress as our spear. We invite researchers worldwide to join us in overcoming technological barriers and building a resilient supply chain for life science and biopharmaceutical innovation.
Together We Advance Science! Starter Antibodies Accelerate Your Research!
Starter: Your Trusted Antibody Expert
